Press Releases
This section of Viatris.com contains information that may not be suitable for use in all countries due to varied regulatory requirements, data protection requirements and practices or medical practices, and distinctions among product approval and commercial availability. The information contained in each news release or statement posted on this page is presented as of the date it was issued. The company undertakes no obligation to update the information for changes or subsequent events after the date it was originally issued.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Jun 23, 2021Company Confident Evidence Regarding Only Remaining Claim Will Show Mylan's Actions Were Lawful and Pro-competitive
- May 6, 2021New company highlights patients, holistic approach to providing access to medicine, and path to further progress
- Mar 8, 2021Milestone reinforces Viatris' commitment to complex products and innovative solutions to help increase patient access
- Feb 9, 2021Viatris to host its inaugural virtual Investor Day on March 1, 2021, as previously announced
- Dec 11, 2020Initiative to Ensure Company is Set Up to Meet its Stated Commitments in Order to Deliver Sustainable Value to Patients, Customers, Shareholders and other Stakeholders
- Dec 7, 2020
New animations and materials featuring the Sesame Street Muppets address key emotions that families are feeling during the COVID-19 pandemic - Nov 23, 2020Tentative approval will help enhance access to WHO-recommended pediatric medicine and reduce the cost of HIV treatment for children in low- and middle-income countries
- Nov 16, 2020Combination of Mylan and Pfizer's Upjohn Business Focused on Access and Improved Patient Health
- Oct 30, 2020Pfizer Announces Record Date for the Proposed Transaction
- Sep 15, 2020The Companies Have Also Received Approvals in Australia and New Zealand; Combination on Track to Close in Fourth Quarter 2020
- Jul 9, 2020Announcement follows Mylan shareholder approval of Mylan's combination with Pfizer's Upjohn
- Jun 30, 202099.6% of Shares Voted in Favor of the Transaction
- Mar 26, 2020Due to global impact of COVID-19 pandemic, transaction now expected to close in the second half of 2020 and Mylan's EGM moved to June 30
- Feb 27, 2020Pfizer's Upjohn Division CFO Sanjeev Narula selected for leadership role at combined company
- Feb 27, 202013 Inaugural Directors Bring Wide-Ranging Experience, Expertise and a Focus on Driving Shareholder Value
- Dec 18, 2019Ian Read and James Kilts offer strong experience to support long-term value creation
- Jul 29, 2019Delivers enhanced global scale and geographic reach, including leading positions in China and other emerging markets